Home
Press releasesPress Releases
Recent press, briefings and insights help you stay informed about our latest product and solution developments.
-
Quotient Limited Expands MosaiQ Innovator’s Circle to Empower Patient Care and Laboratory Efficiencies
JERSEY, Channel Islands, 24 August 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient), headquartered in Eysins, Switzerland, today announced the National Screening Laboratory of Sanquin Blood Supply Foundation, Department Research & Labservices (Sanquin), headquartered in Amsterdam, the Netherlands has joined MosaiQ Innovator’s Circle. Sanquin Blood Supply is responsible for safe and…
-
Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
JERSEY, Channel Islands, June 8, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced an agreement with Theradiag, a market leader in autoimmune disease testing and pioneer in theranostics, under which the two companies will partner to advance autoimmune diagnostics by leveraging Quotient’s MosaiQ platform. Under the new agreement, Theradiag will…
-
Quotient Limited Announces Opening of Office in Dubai, United Arab Emirates
Diversified global presence key to Company’s go-to-market strategy Strengthened geographical expansion with distributor strategy model to better support customers in the region JERSEY, Channel Islands, May 17, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced the opening of its new office in Dubai, UAE, and the incorporation of…
-
Quotient Limited to Host Key Opinion Leader Webinar on its MosaiQ™ Solution
JERSEY, Channel Islands, May 12, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company, today announced that it will host a key opinion leader (KOL) webinar on the current landscape and unmet needs within blood grouping and donor disease screening on Monday, May 23, 2022 at 11:00am ET. The virtual webinar will…
-
Quotient Limited Further Strengthens Scientific and Medical Synergies with the Expansion of the MosaiQ Innovator’s Circle
New York Blood Center, Inc. and Centro de Transfusiones de la Comunidad de Madrid join MosaiQ’s Innovator’s Circle in partnership to improve patient care and laboratory efficiencies JERSEY, Channel Islands, 21 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced New York Blood Center,…
-
Quotient Limited Announces Receipt of CE Mark for the Extended Immunohematology Microarray
The Extended Immunohematology microarray provides labs with comprehensive characterization, simplified workflow, and high throughput—all on a single multimodal multiplexing platform JERSEY, Channel Islands, 8 March 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced it has received Conformité Européenne (CE) Mark for its MosaiQ…
-
Quotient Limited Launches Scientific Advisory Board and Research Programs
MosaiQ virtual Scientific Advisory Board (SAB) was attended this week by eight Key Opinion Leaders (KOLs) from the US and various European countries Quotient’s focus is to strengthen MosaiQ scientific and medical evidence through the Innovator’s Circle and Investigator Initiated research programs Quotient is initiating studies to demonstrate operational value and workflow benefits within the…
-
Quotient Limited Provides Update on MosaiQ Expanded Immunohematology Microarray CE Marking Progress
Received feedback from the European notified body after review of Expanded IH submission Pleased with feedback and expect to submit a response to the questions in the next couple of weeks Continue to expect approval in Q1 CY 2022 JERSEY, Channel Islands, December 15, 2021 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ: QTNT), a commercial-stage…
-
Quotient Limited Announces Appointment of Chief Manufacturing Operations Officer
“It is my pleasure to welcome Esteban to the Executive team at this exciting time in our Company’s evolution. Esteban brings his experience in leading high-growth teams and unifying manufacturing and supply chain management. As we transition the company from the development phase into commercialization, we will drive scale up in manufacturing to transform the…
-
Quotient Limited Announces Appointment of Chief Financial Officer
“I am delighted to welcome Ali to the Executive team at this exciting time in our Company’s evolution. He brings over 20 years of experience in global finance and has been a key driver of operational excellence in a career spanning healthcare services and manufacturing. I worked with Ali at Quest and was impressed by…
